Clues From Gaucher's Disease Firm Up New Treatment Strategy For Neurodegeneration
This article was originally published in Start Up
Research linking the cause of the rare genetic disorder Gaucher's disease to mechanisms at work in Parkinsonism and other neurodegenerative conditions could become the underpinning for a broad strategy to treat neurodegeneration. It's part of a growing trend looking at molecular activities in the lysosome, a cellular compartment, for drug targets.
You may also be interested in...
US FDA not planning an advisory committee for Pfizer/BioNTech’s request for authorization in 12-15-year olds at this time, but CDC’s ACIP is likely to weigh how to balance timing of COVID vaccination with administration of other immunizations generally recommended for adolescents.
HIV community is pushing back against the change, arguing that revenue lost from reduced reimbursement will cripple providers, which use the extra funds for wrap-around patient support and services.
Pfizer is looking to address breast cancer resistant to Ibrance and other CDK4/6 inhibitors, but sees potential paths to earlier lines of treatment and additional tumors.